UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Diez, P., Hanna, G.G., Aitken, K.L. et al. (18 more authors) (2022) UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Clinical Oncology, 34 (5). pp. 288-300. ISSN 0936-6555

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Diez, P.
  • Hanna, G.G.
  • Aitken, K.L.
  • van As, N.
  • Carver, A.
  • Colaco, R.J.
  • Conibear, J.
  • Dunne, E.M.
  • Eaton, D.J.
  • Franks, K.N.
  • Good, J.S.
  • Harrow, S.
  • Hatfield, P.
  • Hawkins, M.A.
  • Jain, S.
  • McDonald, F.
  • Patel, R.
  • Rackley, T.
  • Sanghera, P.
  • Tree, A.
  • Murray, L. ORCID logo https://orcid.org/0000-0003-0658-6455
Copyright, Publisher and Additional Information:

© 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. This is an author produced version of an article published in Clinical Oncology made available under the CC-BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0) in accordance with the publisher's self-archiving policy.

Keywords: Constraints; normal tissue; OAR; SABR; SBRT; stereotactic radiotherapy
Dates:
  • Published: May 2022
  • Published (online): 7 March 2022
  • Accepted: 14 February 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Depositing User: Symplectic Publications
Date Deposited: 13 Jun 2024 15:18
Last Modified: 13 Jun 2024 15:18
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.clon.2022.02.010
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics